Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forteo for Craniofacial Osseous Regeneration in Dental Implants
NCT01279187Phase 2Terminated
- Sponsor
- University of Michigan
- Start
- Feb 2011
- Primary completion
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of teriparatide in tooth loss (2 arms), sponsored by University of Michigan. Primary endpoint: Bone Formation Rate at 10 weeks. Started Feb 2011; status: terminated.
02
Drugs
teriparatide
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT01279187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279187.